All
Daily Derm Times: July 22, 2025
Catch up on dermatology news, highlights, and insights from the past 24 hours.
Psychological Stress Impairs Wound Healing and Collagen Production, New Review Confirms
Updated research finds that chronic stress disrupts healing processes and scar treatments, limiting the effectiveness of wound care in some patients.
Lars French, MD: Turning Global Skin Health Policy into Action for Patients
Lars French, MD, explains how the new WHA resolution on skin health could drive training, access, and global policy change.
Claire Fuller, MA, FRCP: WHA Resolution on Skin Diseases Marks a Global Turning Point for Dermatologic Health
A new WHA resolution spotlights skin health, pushing member states to close care gaps and integrate dermatology into public health.
Sun Pharma Announces Positive Phase 3 Results for Tildrakizumab in Psoriatic Arthritis
Sun Pharma reveals promising phase 3 results for tildrakizumab (Ilumya) in treating PsA, showing significant symptom improvement in patients.
Beyond Efficacy: Why We Need a New Look at Drug Safety
Matthew Zirwas, MD, discusses the complexities of safety analysis in psoriasis clinical trials, advocating for exposure-adjusted incidence rates to enhance risk communication.
Social Media Fails on Retinol Safety Education
Social media spreads significant retinol misinformation, risking adolescent skin health. Experts call for improved digital education and accurate content creation.
FDA Issues CRL for RP1 and Nivolumab in Melanoma
Replimune faces FDA challenges for RP1's approval in advanced melanoma, highlighting complexities in cancer drug development and regulatory scrutiny.
Practical Pearls for Managing Vitiligo Across Skin Types and Life Stages
Topical ruxolitinib, phototherapy, and psychosocial care took center stage in an interactive discussion between Seemal Desai, MD, FAAD, and colleagues, on managing complex vitiligo cases.
Daily Derm Times: July 21, 2025
Empowering Patients and Families in the Management of Vitiligo
At a recent Dermatology Times Case-Based Roundtable event, Stephanie Simmerman, DNP, APRN-C, discussed treatment selection, access challenges, and more for patients with vitiligo.
Q&A with Steven Dayan, MD, FACS: Unpacking the Full Impact of Neurotoxins with Patient-Reported Outcomes
According to new research from Steven Dayan, MD, FACS, PROs are reshaping aesthetic medicine, enhancing Botox treatment insights and prioritizing holistic patient care.
FDA Accepts sNDA for Sotyktu in PsA
Bristol Myers Squibb's deucravacitinib gains global regulatory acceptance for treating active psoriatic arthritis, promising a new oral treatment option.
Fall Clinical PA/NP 2025: PAs and NPs Take Control of Their Future
The 2025 Fall Clinical Dermatology Conference energized PAs and NPs with innovative strategies, addressing burnout, digital branding, and personalized medicine.
Johnson & Johnson Submits NDA for Icotrokinra in Plaque Psoriasis
Johnson & Johnson submitted an NDA for icotrokinra, a promising new treatment for moderate to severe plaque psoriasis in adults and adolescents.
Apremilast Shows Promise in Genital Psoriasis
A retrospective case series found that apremilast induced complete remission in 6 men with treatment-resistant genital psoriasis.
Dermatology Times' Weekly Crossword: July 20, 2025
Test your knowledge of key words and terms associated with dermatology news from the previous week.
Top 5 Articles of the Week: July 13-18
Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.
The Weekly Roundup: July 14-18
In case you missed it, this week we had news about the launch of deuruxolitinib for alopecia areata, Treg cel impairment in vitiligo, the top aesthetic innovations of this month, and more.
The Rx Recap: July 13-18
This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.
Dermatology Times Spot Test: July 19, 2025
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
Daily Derm Times: July 18, 2025
Women Have Higher Levels of Work and Life Burden Due to Dermatological Conditions Versus Men
New research highlights the significant impact of dermatological diseases on work-life balance, revealing greater burdens for women compared to men.
Robert Sidbury, MD, MPH, Leaves a Lasting Legacy in Pediatric Care
The dermatology community mourns the loss of Dr. Robert Sidbury, a visionary leader in pediatric dermatology, whose impact and mentorship resonate deeply.
Age Influences Allergen Sensitivity and Reaction Severity in Patch Testing
Elderly patients show lower and more mild patch test reactivity than younger individuals, with different sensitization patterns.
Acne Burden is Growing in Young Women Across the World, New Study Finds
Global acne burden in reproductive-age women has risen significantly, with greater increases expected by 2040.
The Value of RAD, According to Clinicians
Experts share how this year's RAD Conference showcased cutting-edge advancements in atopic dermatitis to enhance patient care and treatment strategies.
A Million Ways to Get Behind in a Dermatology Clinic
Hershel Dobkin, MD, FAAD, shares his experiences and the surprising reasons behind clinic delays, from patient needs to unexpected moments.
Daily Derm Times: July 17, 2025
Consulting, Care, and the Direct Pay Future with Jacki Kment, PA-C, MPAS, DFAAPA
Jacki Kment, PA-C, MPAS, DFAAPA, shares how she built a successful direct pay dermatology practice to prioritize patient care and professional balance.
